Work

S0901 Tofacitinib for the Treatment of Ulcerative Colitis: An Update on the Analysis of Malignancy Rates From the Ulcerative Colitis Clinical Program as of May 2019

Year: 2020

Type: article

Source: The American Journal of Gastroenterology

DOI: 10.14309/01.ajg.0000705652.98912.de

Authors: Gary R. Lichtenstein, Matthew A. Ciorba, Gerhard Rogler, Ala Sharara, Nancy Sunna, Rajiv Mundayat, Donna T. Judd, Nervin Lawendy, Julian Panés

Institutions: University of Pennsylvania, Washington University in St. Louis, University of Zurich, American University of Beirut Medical Center, Pfizer (United States), Hospital Clínic de Barcelona, Consorci Institut D'Investigacions Biomediques August Pi I Sunyer

Language: English

Topic: Inflammatory Bowel Disease

Subfield: Genetics

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W3093870032

FWCI:

Cites: 2

Cited by:

Related to: 10